ARCHIVES

ORI Final Findings Of Scientific Misconduct

This article is from The Cancer Letter archive.

Vol. 20 No. 35 | September 16, 1994

Download PDF Visit The Full Archive

Related Articles

Mace Rothenberg Leaves Vanderbilt For Pfizer Oncology.

November 14, 2008

Results of NSABP Studies Unchanged When Falsified Data is Excluded: Fisher

May 27, 1994

In Brief: James Downing named CEO of St. Jude

June 27, 2014

In Brief: Cancer Act Renewal Hearings Completed ; Administration Stays With Objections To More Centers, Specific Budget Figures

February 22, 1974

In Brief: NCI Holds Paylines To 160, 165 for Now While Anticipating Another OMB Rescission Request

November 14, 1986

Charles Moertel, Mayo Clinic Investigator, Advocate Of Rigorous Trials, Dead At 66

July 8, 1994